Astgen Leboeuf SRL
Astgen Leboeuf reported total assets of 378,915 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of Astgen Leboeuf shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Astgen Leboeuf's annual accounts
| 2025 | |
|---|---|
| Net result | 50,096 € |
| Equity | 70,096 € |
| Cash | 84,588 € |
| EBITDA | 79,648 € |
| Total assets | 378,915 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
Astgen Leboeuf's financial analysis
- Solvency18.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Astgen Leboeuf
Astgen Leboeuf's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1023.100.570
- VAT number
- BE1023100570
- Peppol
- Registered · 0208:1023100570 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 May 2025
- Registered office
- 1200 Woluwe-Saint-Lambert
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Astgen Leboeuf (SRL) has been based in Woluwe-Saint-Lambert since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 50,096 € and equity of 70,096 €; its revenue is not published. Its solvency stands at 18.5%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Astgen Leboeuf
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Parent Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 304,281 €
- Lifetime Energy Retail sale of pharmaceutical products Wommelgem · balance sheet 287,751 €
- Care Farma Retail sale of pharmaceutical products Juprelle · balance sheet 456,092 €
- Pharmaq Retail sale of pharmaceutical products Mons · balance sheet 375,271 €
- Apotheek Vrijbroek Retail sale of pharmaceutical products Mechelen · balance sheet 387,647 €
- Kourion.BE Retail sale of medical and orthopaedic goods Bertem · balance sheet 325,956 €
- Curapharma Retail sale of pharmaceutical products Zaventem · balance sheet 352,271 €
- Paracelsus Retail sale of pharmaceutical products Aalst · balance sheet 413,042 €
Frequently asked questions about Astgen Leboeuf
What is the revenue of Astgen Leboeuf?
Astgen Leboeuf files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Astgen Leboeuf?
In Belgium, the VAT number is the company number prefixed with BE: BE1023100570 for Astgen Leboeuf, if the company is VAT-registered. Its company number (CBE) is 1023.100.570.
Where is the registered office of Astgen Leboeuf?
According to the CBE register, the registered office of Astgen Leboeuf is in 1200 Woluwe-Saint-Lambert.
What is the equity of Astgen Leboeuf?
At the close of the 2025 financial year, the equity of Astgen Leboeuf amounts to 70,096 €, a solvency of 18.5% of total assets.
Who manages Astgen Leboeuf?
The register lists 4 active mandates at Astgen Leboeuf. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Astgen Leboeuf
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →